1-5 of 5
Chia-Jui Yen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors

Free
John H. Strickler, Patricia LoRusso, Ravi Salgia, Yoon-Koo Kang, Chia Jui Yen, Chia-Chi Lin, Peter Ansell, Monica Motwani, Shekman Wong, Huibin Yue, Lan Wang, Edward Reilly, Daniel Afar, Louie Naumovski, Ramesh K. Ramanathan
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (5): 1210–1217.
https://doi.org/10.1158/1535-7163.MCT-19-0529
Published: 04 May 2020
View article titled, Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs

Free
Hong-Yi Chang, Ting-Chia Chang, Wen-Ya Huang, Chung-Ta Lee, Chia-Jui Yen, Yuh-Shyan Tsai, Tzong-Shin Tzai, Shu-Hui Chen, Nan-Haw Chow
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (2): 276–286.
https://doi.org/10.1158/1535-7163.MCT-15-0311
Published: 07 February 2016
View article titled, RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs
Open the PDF for RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs in another window
Includes: Supplementary data
Journal Articles

HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells

Free
Chien-Feng Li, Hsin-Hwa Tsai, Chiung-Yuan Ko, Yen-Chun Pan, Chia-Jui Yen, Hong-Yue Lai, Chiou-Hwa Yuh, Wan-Chen Wu, Ju-Ming Wang
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (11): 2623–2633.
https://doi.org/10.1158/1535-7163.MCT-15-0025
Published: 03 November 2015
View article titled, HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells
Open the PDF for HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Abstract A46: Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN)

Free
Pamela Munster, Moshe Elkabets, Jill Gilbert, Albiruni R Abdul Razak, Myung-Ju Ahn, Chia-Jui Yen, Se-Hoon Lee, Hung-Ming Wang, Carla van Herpen, Wan-Teck Lim, David Demanse, Rupam Ranjan Pal, Alan Huang, Qing Sheng, Chiara Lambertini, Malte Peters, Christina Coughlin, Maurizio Scaltriti, José Baselga, George Blumenschein
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): A46.
https://doi.org/10.1158/1538-8514.PI3K14-A46
Published: 06 July 2015
View article titled, Abstract A46: Inhibition of PIK3CA with BYL719 can overcome resistance to cetuximab in squamous cell carcinoma of the head and neck (SCCHN)
Journal Articles

Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase

Free
Chun-Te Chen, Hirohito Yamaguchi, Hong-Jen Lee, Yi Du, Heng-Huan Lee, Weiya Xia, Wen-Hsuan Yu, Jennifer L. Hsu, Chia-Jui Yen, Hui-Lung Sun, Yan Wang, Edward T.H. Yeh, Gabriel N. Hortobagyi, Mien-Chie Hung
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (8): 1327–1336.
https://doi.org/10.1158/1535-7163.MCT-10-1117
Published: 08 August 2011
View article titled, Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
Open the PDF for Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase in another window
Includes: Supplementary data